Last updated: June 1, 2025
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Macular Edema
Cystoid Macular Edema
Geographic Atrophy
Treatment
Procedure video viewing
Clinical Study ID
NCT07002372
2024-1393
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Patients who are receiving their first intravitreal injection of anti-VEGFmedication due to retinal diseases
Mentally competent, and able to communicate without barriers
Willing to voluntarily sign an informed consent form.
Exclusion
Exclusion Criteria:
History of previous eye surgery
Best-corrected visual acuity in the better eye worse than 0.3
The target eye is complicated with neovascular glaucoma.
Study Design
Total Participants: 182
Treatment Group(s): 1
Primary Treatment: Procedure video viewing
Phase:
Study Start date:
May 05, 2025
Estimated Completion Date:
October 05, 2025
Connect with a study center
Second Affiliated Hospital, School of Medicine, Zhejiang University
Hangzhou, 浙江省 310009
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.